Wenmei Jiang

749 total citations · 1 hit paper
18 papers, 512 citations indexed

About

Wenmei Jiang is a scholar working on Surgery, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Wenmei Jiang has authored 18 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Otorhinolaryngology. Recurrent topics in Wenmei Jiang's work include Head and Neck Cancer Studies (6 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Wenmei Jiang is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Wenmei Jiang collaborates with scholars based in China, United Kingdom and United States. Wenmei Jiang's co-authors include Mihrimah Ozkan, Yanjie Lu, Yilin Xie, Zhenwei Pan, Hao Wu, Linfeng Zhan, Yin Yuan, Haixia Zhu, Jifan Zhang and Shenjian Luo and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Journal of Molecular and Cellular Cardiology.

In The Last Decade

Wenmei Jiang

16 papers receiving 502 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current status and pillars of direct air capture technologies

2022 207 citations Mihrimah Ozkan, Wenmei Jiang et al. iScience profile →

Peers

Countries citing papers authored by Wenmei Jiang

Since Specialization

Citations

This map shows the geographic impact of Wenmei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmei Jiang more than expected).

Fields of papers citing papers by Wenmei Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenmei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmei Jiang. The network helps show where Wenmei Jiang may publish in the future.

Co-authorship network of co-authors of Wenmei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenmei Jiang. A scholar is included among the top collaborators of Wenmei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenmei Jiang. Wenmei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Prognostic value of positive lymph node ratio in oral cavity squamous cell carcinoma after neoadjuvant treatment: a retrospective real-world study 2025 ·Scientific Reports ·(unknown), (unknown), Yun Cheng, Yimin Wu, Wenmei Jiang	0
2	Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary 2025 ·Cancer Medicine ·(unknown), Shuwen Fu, (unknown), Wenmei Jiang, (unknown), Ruiyu Li, (unknown), Mingyuan Du, (unknown), Quan Zhang, Shu-Wei Chen	0
3	Is KRAS (G12C) inhibitor monotherapy for non-small cell lung cancer possible? A review of current literature 2025 ·Jian Zeng, Wenmei Jiang, Leilei Wu	1
4	The molecular characteristics could supplement the staging system of pT2/T3N0M0 esophageal squamous cell carcinoma: a translational study based on a cohort with over 20 years of follow-up 2024 ·Cancer Cell International ·Wenmei Jiang, (unknown), (unknown), Lihong Qiu, Xingyu Luo, (unknown), Hao Long, Lanjun Zhang, Peng Lin, Xinxin Xu, Lei‐Lei Wu, (unknown)	1
5	High-risk characteristics of pathological stage I lung adenocarcinoma after resection: patients for whom adjuvant chemotherapy should be performed 2023 ·Heliyon ·Lei‐Lei Wu, Wenmei Jiang, Jiayi Qian, (unknown), Zhixin Li, Kun Li, Guowei Ma, Dong Xie, Chang Chen	4
6	Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma 2023 ·Clinical & Translational Oncology ·(unknown), Lili Liu, (unknown), Lijun Wei, Wenmei Jiang, (unknown), Ankui Yang, Xuekui Liu, Wenkuan Chen, Yan‐Feng Chen, Hui Li, Qiaohong Lin, Meng-Hua Li, Jingtao Chen, Quan Zhang, Shuwei Chen, Ming Song	5
7	AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research 2023 ·Discover Oncology ·Lei‐Lei Wu, Wenmei Jiang, Zhiyuan Liu, (unknown), Jiayi Qian, Yue Liu, (unknown), (unknown), Zhixin Li, (unknown), Dong Xie	2
8	Prognostic risk factor of major salivary gland carcinomas and survival prediction model based on random survival forests 2023 ·Cancer Medicine ·(unknown), (unknown), Guoli Li, Wenmei Jiang, (unknown), (unknown), (unknown), Yan‐Feng Chen, Hao Li, (unknown), (unknown)	11
9	The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma 2023 ·Journal of Personalized Medicine ·Wenmei Jiang, Yan Li, Ruiyu Li, Wenkuan Chen, Ming Song, Quan Zhang, (unknown)	3
10	Relationship between lymph nodes examined and survival benefits with postoperative radiotherapy in oral cavity squamous cell carcinoma patients with stage T1-2N1M0 2022 ·Frontiers in Surgery ·(unknown), Wenmei Jiang, (unknown), Ruiyu Li, Yudong Li, Yan‐Feng Chen, Quan Zhang	4
11	Prediction of Long-Term Survival Outcome by Lymph Node Ratio in Patients of Parotid Gland Cancer: A Retrospective study 2022 ·Frontiers in Surgery ·Wenmei Jiang, Jianfeng Xu, Jun Chen, Guoli Li, Yunfei Gao, Quan Zhang, Yan‐Feng Chen	3
12	Current status and pillars of direct air capture technologies breakdown → 2022 ·iScience ·Mihrimah Ozkan, (unknown), (unknown), Wenmei Jiang	207
13	A Nomogram to Predict Long-Term Survival Outcomes of Patients Who Undergo Pneumonectomy for Non-small Cell Lung Cancer With Stage I-IIIB 2021 ·Frontiers in Surgery ·Lei‐Lei Wu, (unknown), Xuan Liu, Wenmei Jiang, (unknown), Peng Lin, Hao Long, Lanjun Zhang, Guowei Ma	8
14	A Parsimonious Prognostic Model and Heat Map for Predicting Survival Following Adjuvant Radiotherapy in Parotid Gland Carcinoma With Lymph Node Metastasis 2021 ·Technology in Cancer Research & Treatment ·Wenmei Jiang, Lei‐Lei Wu, (unknown), (unknown), Quan Zhang	2
15	Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual 2020 ·Frontiers in Oncology ·Lei‐Lei Wu, Xuan Liu, Wenmei Jiang, Wei Huang, Peng Lin, Hao Long, Lanjun Zhang, Guowei Ma	30
16	Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts 2020 ·The FASEB Journal ·Tingting Li, Yuting Zhuang, Wanqi Yang, Yilin Xie, (unknown), Shuang Su, Xue Dong, (unknown), Wenmei Jiang, Yang Zhou, Ying Li, Xin Zhou, Mingyu Zhang, Yanjie Lu, Zhenwei Pan	101
17	lncRNA H19 Alleviated Myocardial I/RI via Suppressing miR-877-3p/Bcl-2-Mediated Mitochondrial Apoptosis 2019 ·Molecular Therapy — Nucleic Acids ·(unknown), Shenjian Luo, Jifan Zhang, Yin Yuan, Wenmei Jiang, Haixia Zhu, (unknown), Linfeng Zhan, Hao Wu, Yilin Xie, Rui Song, Zhenwei Pan, Yanjie Lu	86
18	LncRNA PCFL promotes cardiac fibrosis via miR-378/GRB2 pathway following myocardial infarction 2019 ·Journal of Molecular and Cellular Cardiology ·Fei Sun, Yuting Zhuang, Haixia Zhu, Hao Wu, Danyang Li, Linfeng Zhan, Wanqi Yang, Yin Yuan, Yilin Xie, Shuang Yang, Shenjian Luo, Wenmei Jiang, Jifan Zhang, Zhenwei Pan, Yanjie Lu	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact